These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1674017)

  • 1. Treatment for stroke?
    Lancet; 1991 May; 337(8750):1129-31. PubMed ID: 1674017
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
    Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
    Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia?
    Albers GW; Goldberg MP; Choi DW
    Ann Neurol; 1989 Apr; 25(4):398-403. PubMed ID: 2565699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia.
    Albers GW
    Clin Neuropharmacol; 1990 Jun; 13(3):177-97. PubMed ID: 1972652
    [No Abstract]   [Full Text] [Related]  

  • 5. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia.
    Stevens MK; Yaksh TL
    J Cereb Blood Flow Metab; 1990 Jan; 10(1):77-88. PubMed ID: 2153692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells.
    Morley P; Small DL; Murray CL; Mealing GA; Poulter MO; Durkin JP; Stanimirovic DB
    J Cereb Blood Flow Metab; 1998 Apr; 18(4):396-406. PubMed ID: 9538905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
    Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lowering blood pressure permits limiting cerebral microangiopathy].
    Tzourio C; Dufouil C; Tzourio-Mazoyer N
    Med Sci (Paris); 2006 Feb; 22(2):104-5. PubMed ID: 16457741
    [No Abstract]   [Full Text] [Related]  

  • 9. A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.
    Zhang Y; Belayev L; Zhao W; Irving EA; Busto R; Ginsberg MD
    Brain Res; 2005 May; 1045(1-2):150-6. PubMed ID: 15910773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced hypertension improves cerebral blood flow in acute ischemic stroke.
    Chalela JA; Dunn B; Todd JW; Warach S
    Neurology; 2005 Jun; 64(11):1979. PubMed ID: 15955961
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium and glutamate-induced cortical neuronal death.
    Choi DW; Hartley DM
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():23-34. PubMed ID: 8093332
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.
    Okada M; Ueda H; Kometani M; Nakao K
    Arzneimittelforschung; 1997 Jun; 47(6):703-5. PubMed ID: 9239446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat.
    Jiang N; Finklestein SP; Do T; Caday CG; Charette M; Chopp M
    J Neurol Sci; 1996 Aug; 139(2):173-9. PubMed ID: 8856649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flunarizine, a calcium channel antagonist, is not neuroprotective when given after hypoxia-ischemia in the infant rat.
    Gunn AJ; Gluckman PD
    Dev Pharmacol Ther; 1991; 17(3-4):205-9. PubMed ID: 1841839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
    Graham SH; Chen J; Lan JQ; Simon RP
    J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the level of auto-antibodies for the NMDA type glutamate receptors in diagnosis of chronic cerebral circulation disorders].
    Khunteev GA; Zavolokov IG; Cherkas IuV; Dambinova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(11):44-7. PubMed ID: 11765613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of calcium antagonist nimodipine and induced hypertension on cerebral vessel reactivities, cerebral blood flow, cerebral edema and infarction in cats with one hour middle-cerebral-artery occlusion].
    Sakaki T; Ishida T; Sasaoka Y; Thunoda S; Utsumi S
    No Shinkei Geka; 1990 May; 18(5):423-30. PubMed ID: 2385317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Recanalization after intravenous thrombolysis: does a recanalization time window exist?
    Gotkine M; Rosenberg G; Steiner I
    Neurology; 2008 Jan; 70(5):406; author reply 406-7. PubMed ID: 18227425
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical management of acute cerebral ischemia.
    Biller J
    Neurol Clin; 1992 Feb; 10(1):63-85. PubMed ID: 1557010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracarotid injection of granulocyte-macrophage colony-stimulating factor induces neuroprotection in a rat transient middle cerebral artery occlusion model.
    Nakagawa T; Suga S; Kawase T; Toda M
    Brain Res; 2006 May; 1089(1):179-85. PubMed ID: 16678804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.